MARFIA, GIROLAMA ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 47.059
EU - Europa 10.108
AS - Asia 7.930
SA - Sud America 1.041
AF - Africa 94
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 13
Totale 66.264
Nazione #
US - Stati Uniti d'America 46.855
IT - Italia 5.645
SG - Singapore 4.010
CN - Cina 1.163
BR - Brasile 872
RU - Federazione Russa 839
HK - Hong Kong 739
KR - Corea 677
DE - Germania 661
IE - Irlanda 606
VN - Vietnam 562
UA - Ucraina 539
FR - Francia 433
GB - Regno Unito 352
JP - Giappone 233
SE - Svezia 220
NL - Olanda 207
FI - Finlandia 198
IN - India 132
CA - Canada 118
PL - Polonia 110
BD - Bangladesh 61
AR - Argentina 57
AT - Austria 56
MX - Messico 51
CH - Svizzera 49
TR - Turchia 46
IQ - Iraq 45
ES - Italia 39
ID - Indonesia 38
ZA - Sudafrica 35
BE - Belgio 29
RO - Romania 28
CL - Cile 26
EC - Ecuador 25
IR - Iran 23
PH - Filippine 23
UZ - Uzbekistan 22
PK - Pakistan 21
SA - Arabia Saudita 20
MY - Malesia 17
CO - Colombia 16
EG - Egitto 16
CZ - Repubblica Ceca 15
GR - Grecia 14
MA - Marocco 14
PY - Paraguay 14
EU - Europa 12
KG - Kirghizistan 12
AU - Australia 11
VE - Venezuela 11
AZ - Azerbaigian 10
HR - Croazia 10
LT - Lituania 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
NP - Nepal 9
TT - Trinidad e Tobago 9
KE - Kenya 8
TH - Thailandia 8
UY - Uruguay 8
DZ - Algeria 7
NO - Norvegia 7
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DO - Repubblica Dominicana 5
IL - Israele 5
JM - Giamaica 5
JO - Giordania 5
TN - Tunisia 5
DK - Danimarca 4
LB - Libano 4
LU - Lussemburgo 4
OM - Oman 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BG - Bulgaria 3
BH - Bahrain 3
BS - Bahamas 3
GE - Georgia 3
NG - Nigeria 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
CY - Cipro 2
ET - Etiopia 2
HN - Honduras 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NI - Nicaragua 2
PA - Panama 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
BA - Bosnia-Erzegovina 1
Totale 66.245
Città #
Wilmington 12.528
Houston 11.472
Woodbridge 11.457
Singapore 1.730
Fairfield 1.149
San Jose 870
Chandler 859
Ann Arbor 797
Ashburn 760
Hong Kong 727
Rome 646
Dublin 554
Milan 460
Seattle 451
Cambridge 429
Beijing 422
New York 389
Medford 373
Jacksonville 363
Dearborn 318
Santa Clara 297
The Dalles 230
Los Angeles 194
Ho Chi Minh City 188
Tokyo 187
Lawrence 175
Dallas 163
Lauterbourg 148
Moscow 144
Council Bluffs 143
Bologna 134
Hanoi 131
Buffalo 128
Turin 105
Naples 93
São Paulo 90
Torino 81
Zhengzhou 81
Verona 78
San Diego 77
Kraków 67
North Bergen 67
Florence 65
Helsinki 61
Creede 53
Redondo Beach 51
London 49
Nuremberg 49
Padova 48
Redwood City 48
Orem 47
Chicago 45
Munich 44
Norwalk 44
Mülheim 43
Menlo Park 42
Trento 41
Frankfurt am Main 40
Atlanta 36
Genoa 35
Palo Alto 35
Piove di Sacco 35
Roebling 35
Brescia 34
Palermo 33
Lappeenranta 32
Seoul 32
Bari 31
Pavia 30
Toronto 27
Warsaw 27
Jakarta 26
Montreal 26
Amsterdam 25
Brussels 25
Salt Lake City 25
Shanghai 24
Bergamo 23
Brooklyn 23
Stockholm 23
Belo Horizonte 22
Boardman 22
Cagliari 22
Guangzhou 22
Nanjing 22
San Francisco 22
Chennai 21
Da Nang 21
Haiphong 21
Mcallen 21
Monza 21
Phoenix 21
Catania 20
Elk Grove Village 20
Hefei 20
Ottawa 20
Parma 20
Rio de Janeiro 20
Falls Church 19
Mountain View 19
Totale 51.583
Nome #
Batteria per la valutazione del Deterioramento Mentale (parte II): standardizzazione e affidabilità diagnostica nell’identificazione di pazienti affetti da sindrome demenziale 2.487
Batteria per la valutazione del Deterioramento Mentale (parte I): descrizione di uno strumento di diagnosi neuropsicologica 2.461
Batteria per la valutazione del Deterioramento Mentale (parte III): analisi dei profili qualitativi di compromissione cognitiva 1.017
The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. 714
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease 594
Neurophysiology of synaptic functioning in multiple sclerosis 573
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 571
Posterior cortical atrophy with unilateral occipito-temporal degeneration 561
Explicit memory and repetition priming in dementia: evidence for a common basic mechanism underlying conscious and unconscious retrieval deficits 554
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 549
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 527
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 514
Lexical and conceptual components of stem completion priming in patients with Alzheimer's disease 511
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 510
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 504
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 503
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 503
Brain MR diffusion tensor imaging in Kennedy's disease 498
Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b 497
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 492
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 483
Association of HLA-DQB1∗05:02 and DRB1∗16 Alleles with Late-Onset,Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis 482
Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials 474
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 466
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 462
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 462
Synaptic transmission in the striatum: from plasticity to neurodegeneration 455
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 455
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 452
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study 450
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 449
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 447
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 445
Acute demyelinating sensorimotor polyneuropathy in B-cell lymphoma with IGM autoantibodies against glycolipid GD1B 443
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 440
Perceptual and conceptual components in implicit and explicit stem completion 438
Intestinal pseudobstruction as presenting event of fatal cerivastatin-induced myopathy 437
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 436
Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin 435
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 435
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 432
Italian multicentre study of peroneal mononeuropathy: multiperspective follow-up 431
Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain 431
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 429
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 429
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 426
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 424
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 423
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 423
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 423
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 419
INSULIN AUTOIMMUNE SYNDROME (HIRATA DISEASE) RELATED TO THE ALPHA-LIPOIC ACID ASSUMPTION: CASE REPORT AND REVIEW OF THE LITERATURE 417
The autonomic balance predicts cardiac responses after the first dose of fingolimod 416
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 415
Recency effect in anterograde amnesia: evidence for distinct memory stores underlying enhanced retrieval of terminal items in immediate and delayed recall paradigms 413
Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis 412
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 408
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 408
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 403
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 401
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 400
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 399
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 399
Heidenhain variant in two patients with inherited V210I Creutzfeldt-Jakob disease 398
Glutamate-triggered events inducing corticostriatal long-term depression 397
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum 396
Long latency somatosensory evoked potentials: Modifications after percutaneous tibial nerve stimulation 395
Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons 390
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 390
High sensitivity of autonomic function tests in a case of food-borne botulism 388
Il deterioramento cognitivo nel paziente cerebroleso 388
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 387
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 386
Subclinical autonomic dysfunction in spinobulbar muscular atrophy (Kennedy disease) 385
The neuroprotective agent BW619C89 inhibits neuronal excitability and synaptic transmission in rat corticostriatal slices 385
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 384
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 379
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 377
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 376
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons 371
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory 370
Neuropatie disimmuni 364
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 364
AN ITALIAN MULTICENTER DATABASE FOR THE DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP) AND ITS VARIANTS: DATA FROM THE FIRST 300 PATIENTS 364
Il priming di ripetizione nel deterioramento cognitivo: ipotesi sull’organizzazione della funzione mnesica 362
Efficacy of intravenous immunoglobulin in poems-related relapsing AIDP 360
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 360
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 360
Glutamate-triggered events inducing corticostriatal LTD 359
Modulation of gene expression following long-term synaptic depression in the striatum 358
Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis 357
Myotonic dystrophy unlinked to DM1 and DM2 mutations in three siblings 354
Relapsing aidp responsive to intravenous immunoglobulin in poems syndrome 353
Corticobulbar And Corticospinal Tract Involvement In Kennedy's Disease 352
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 350
Long latency somatosensory evoked potentials: Changes after percutaneous tibial nerve stimulation 348
Nondipping is a novel associated disorder of painful diabetic polyneuropathy 346
Dimethyl fumarate vs. fingolimod in multiple sclerosis: an independent, multi-centre, real world, quasi-randomized study 346
Motor unit number estimation in 30 patients with chronic dysimmune neuropathies 342
Prevalence of anti-neurofascin-155 and anti-contactin-1 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: a serological multicenter study in Italy 342
Totale 47.450
Categoria #
all - tutte 165.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021484 0 0 0 0 0 0 0 0 0 0 354 130
2021/20222.205 142 164 118 187 145 209 132 131 146 183 131 517
2022/20233.352 266 183 299 380 241 610 419 220 278 90 257 109
2023/20241.764 178 62 125 165 142 221 142 127 107 117 89 289
2024/20256.612 228 1.094 631 414 240 486 438 260 630 608 844 739
2025/20268.704 734 458 1.078 642 925 329 1.346 1.115 1.190 876 11 0
Totale 67.262